Quintiles Transnational Corp plans to file for IPO in 18 mths

By Admin
Quintiles Transnational Corp is planning to file for the IPO in next 18 months, the news reports said, citing two people familiar with the situation. Q...

Quintiles Transnational Corp is planning to file for the IPO in next 18 months, the news reports said, citing two people familiar with the situation.

Quintiles is the biggest provider of testing and drug-trial services to pharmaceutical companies. This company was brought in 2008 by private equity companies like TPG Capital and Bain Capital LLC in a deal worth the company at $3.8 billion.

Quintiles is a contract-research company whose revenue growth has accelerated as the drugmakers outsource trials and testing. The company has also appointed a new Chief Executive Officer Tom Pike in April and has brought up a small competitor.

During the past 12 months, Quintiles had $3.53 billion in sales, more than a quarter of the market made up by the 10 biggest contract research companies. It had research partnerships with London-based AstraZeneca Plc, Tokyo-based Eisai Co and Takeda Pharmaceutical Co based in Japan.

TPG and Bain brought Quintiles from One Equity Partners, the private-equity arm of JP Morgan Chase & Co. 3i Group Plc III and Temasek Holdings Pte, Singapore’s state-owned investment company also owns stakes in Quintiles.

Quintiles is a fully integrated biopharmaceutical services company. It offers clinical, commercial, consulting and capital solutions worldwide. The company helps biopharmaceutical companies develop and commercialize products to improve and lengthen patients’ lives. 

Share
Share

Featured Articles

Hyfe AI uses acoustic AI in its digital cough monitoring

Hyfe uses acoustic AI in its digital cough monitoring. Dr. Joe Brew, Co-Founder & CEO of Hyfe AI, tells us more about coughing technology post-COVID-19

Siemens: smart finance to help medical technology growth

Penny Pinnock, Business Development Manager at Siemens Financial Services UK, discusses how adopting digital technology can support the healthcare sector

Healthcare Digital news roundup: prostate cancer & AI

This week in Healthcare Digital, we heard from experts in the sector: Trevor Dearing from Illumio, Avenda Health’s Brit Berry-Pusey & Vish Charan of Abbott

Lexica shares post-COVID-19 digital healthcare trends

Digital Healthcare

Medical devices expanding senior healthcare innovation

Medical Devices & Pharma

Abbott’s CRM medical devices can help cardiac arrhythmia

Medical Devices & Pharma